This study evaluated differences in outcomes for young adults in the United States (U.S.)from lower socioeconomic (SES) backgrounds with type 1 diabetes (T1D) managed on continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) or fixed‐dose insulin (FDI). This evidence concerns the gene INS and type 1 diabetes mellitus.